en-GB
ไทย (TH-TH)
About STADA
Who we are – STADA Thailand
Management
Our Corporate Culture
Products
Quality at STADA TH
Contact
Mobile Navigation
About STADA
About STADA
Who we are – STADA Thailand
Management
Our Corporate Culture
Products
Products
Quality at STADA TH
Contact
en-GB
ไทย (TH-TH)
Blog
Posts
2022
November
STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis®
01/11/2022
Label.BlogRelatedPostsText
STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments
Label.BlogReadMoreText
en-GB